Kite Pharma
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch Kite Pharma and buy or sell other stocks, ETFs, and their options commission-free!About KITE
Kite Pharma, Inc. engages in the the development and commercialization of cancer immunotherapy products. Its products include chimeric antigen receptor (CAR) and T cell receptor (TCR), which address both hematological and solid cancers.
CEOArie S. Belldegrun, MD
CEOArie S. Belldegrun, MD
Employees—
Employees—
HeadquartersSanta Monica, California
HeadquartersSanta Monica, California
Founded2009
Founded2009
Employees—
Employees—
KITE Key Statistics
Market cap10.26B
Market cap10.26B
Price-Earnings ratio-26.17
Price-Earnings ratio-26.17
Dividend yield—
Dividend yield—
Average volume1.77M
Average volume1.77M
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$179.95
52 Week high$179.95
52 Week low$39.82
52 Week low$39.82
Stock Snapshot
As of today, Kite Pharma(KITE) shares are valued at $179.79. The company's market cap stands at 10.26B, with a P/E ratio of -26.17.
On 2026-02-15, Kite Pharma(KITE) shares started trading at —, with intraday highs of — and lows of —.
Trading volume for Kite Pharma(KITE) stock has reached 0, versus its average volume of 1.77M.
The stock's 52-week range extends from a low of $39.82 to a high of $179.95.
The stock's 52-week range extends from a low of $39.82 to a high of $179.95.